Ingevity's ROE % for the quarter that ended in Mar. 2026 was 697.83%. Ingevity's PB Ratio for the quarter that ended in Mar. 2026 was 71.12.
Ingevity's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 9.81%.
Ingevity ROE % Adjusted to Book Value Related Terms
Ingevity ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for Ingevity's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:NGVT vs MTX, KWR, ASH: ROE % Adjusted to Book Value Comparison
For the Specialty Chemicals subindustry, Ingevity's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ingevity ROE % Adjusted to Book Value vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Ingevity's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Ingevity's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 9.81% mean?
Ingevity (MEX:NGVT) has a ROE % Adjusted to Book Value of 9.81% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Ingevity and its competitors.
Is Ingevity's ROE % Adjusted to Book Value too high?
Ingevity's current ROE % Adjusted to Book Value is 9.81%. Overall, Ingevity has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does Ingevity's ROE % Adjusted to Book Value compare to MTX and KWR?
Ingevity's ROE % Adjusted to Book Value of 9.81% can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Chemicals company?
A good ROE % Adjusted to Book Value depends on the Chemicals industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Ingevity and its competitors. Ingevity's current ROE % Adjusted to Book Value is 9.81%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ingevity stock overvalued right now?
Ingevity (MEX:NGVT) has a current ROE % Adjusted to Book Value of 9.81%. The stock's GF Value™ is MXN833.30, compared to a current price of MXN1,430.00 — trading 71.6% above its estimated fair value. The current ROE % Adjusted to Book Value is 9.81%. Ingevity's overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Ingevity (MEX:NGVT), the current ROE % Adjusted to Book Value is 9.81% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ingevity (MEX:NGVT) Overvalued in 2026?
Based on GuruFocus' analysis, Ingevity stock appears to be overvalued.
The current stock price of MXN1,430.00 is trading 71.6% above its estimated GF Value™ of MXN833.30.
Key valuation signals for MEX:NGVT:
ROE % Adjusted to Book Value: 9.81%
GF Value™: MXN833.30 vs. price of MXN1,430.00 (71.6% above fair value)
No single metric tells the full story. See the MEX:NGVT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The company generates the majority of its revenue from North America.
65GF Score
Get the complete analysis for MEX:NGVT
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:NGVT has been successfully added to your 
